Crossmark

A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients

Crossref DOI link: https://doi.org/10.1186/s12885-018-5028-8

Published Online: 2018-11-28

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mao, Minjie

Wang, Xueping

Sheng, Hui

Liu, Yijun

Zhang, Lin

Dai, Shuqin

Chi, Pei-dong http://orcid.org/0000-0002-4682-3737
License Information

Text and Data Mining valid from 2018-11-28
More Information

Article History

Received: 13 March 2018

Accepted: 31 October 2018

First Online: 28 November 2018

Ethics approval and consent to participate

: This study was approved by the Institute Research Ethics Committee of the Sun Yat-Sen University Cancer Center, Guangzhou, China. Each patient provided signed, informed consent.

: Not applicable.

: The authors disclose no competing interests. There are no financial or non-financial competing interests (political, personal, religious, ideological, academic, intellectual, commercial or any other) to declare in relation to this manuscript.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.